Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Aeterna Zentaris Announces Departure of Interim Chief Financial Officer


Posted on: 08 Dec 17

CHARLESTON, S.C., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) (the “Company”) announced today the departure of the Company’s Interim Chief Financial Officer, Jeffrey Whitnell, effective December 7, 2017.  The Company is currently reviewing its resource requirements with respect to its finance department and has commenced a search for Mr. Whitnell's replacement as principal financial officer.

Contact:
Aeterna Zentaris Inc.
Michael V. Ward
Chief Executive Officer, 843.900.3223
IR@AEZSinc.com

Reilly Connect
Susan J. Reilly
President, 312.600.6780
susan.reilly@reillyconnect.com

GlobeNewswire
globenewswire.com

Last updated on: 10/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.